Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT07268586

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07268586
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT07268586. Randomized; triple masking; primary purpose prevention. Start 2025-08-01 (actual); primary completion 2026-02-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Intervention (Drug)
Intravenous atropine immediately before wire crossing during primary percutaneous coronary intervention
Intervention (Drug)
Intravenous normal saline as placebo immediately before wire crossing during primary percutaneous coronary intervention
Lead sponsor
Ain Shams University (class: other)

Record details

Record id
cardio:ct-nct07268586
Content hash
b47c202ec169058148a09145da9707ba7874dfceff7c6ec3787e35bd2306ca78